Records containing: Unspecified Adult Solid Tumor, Protocol Specific
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Study of Bevacizumab in Combination With SU11248
-
CLINICAL_TRIALS study record update · 2014-02-24An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Irinotecan (CPT-11) and Cisplatin in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-24Inhibition of DNA Methylation by 1-Hr Infusion of 5-aza-2'-Deoxycitidine (Decitabine) x 10 Days (M-F) With Escalating Doses of Sub-Q Pegylated (PEG) Interferon-alpha 2B (PEG-Intron): A Phase I Study With Molecular Correlates
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Flavopiridol in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Dose Escalation Study of Daily x 3 Intravenous SJG-136 in Patients With Advanced Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Trial Of 17-Allylaminogeldanamycin (17-AAG) And PS341 In Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Study of Sunitinib Malate and Standard Infusion Gemcitabine in Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Bortezomib in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2014-02-24A Dose Escalation Study of Sorafenib (BAY 43-9006, NSC 724772) in Nomotensive Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2014-02-24A Pilot Study of Flavopiridol in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-24Phase I and Pharmacokinetic Study of Vorinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Study and Pharmacological Trial of Once Weekly Aminoflavone Prodrug (AFP464) Administered 3 Out of Every 4 Weeks in Solid Tumor Patients
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Study of R04929097 in Combination With Gemcitabine in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-19Phase I Clinical Trial Evaluating the Toxicity, Pharmacokinetics and Biological Effect of Intravenous Bevacizumab (Avastin TM) in Combination With Escalating Doses of Oral AZD2171 for Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2014-02-14A Phase II Feasibility and Correlative Study of Probiotic Supplementation in Cancer Patients Receiving Chemotherapy or Tyrosine Kinase Inhibitors (TKIs)
-
CLINICAL_TRIALS study record update · 2014-02-06Enhancing Patient-Oncologist Communication
-
CLINICAL_TRIALS study record update · 2014-02-05A Pilot Phase II Trial of Magnesium Supplements to Reduce Menopausal Hot Flashes in Cancer Patients
-
CLINICAL_TRIALS study record update · 2014-01-31Stress Management Therapy for Patients Undergoing Chemotherapy
-
CLINICAL_TRIALS study record update · 2014-01-31UPMC McKeesport/ROCOG Radiation Oncology Minorities Outreach Program
-
CLINICAL_TRIALS study record update · 2014-01-31Feasibility of a Palliative Care Intervention for Patients on Phase 1 Clinical Trials
-
CLINICAL_TRIALS study record update · 2014-01-30Pilot Study of Fosaprepitant (MK-0517) for Breakthrough Chemotherapy Induced Nausea and Vomiting
-
CLINICAL_TRIALS study record update · 2014-01-16Phase I Study of Monoclonal Antibody Anti-Anb3 Integrin in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-01-13A Phase I Study of Intravenous (IV) Calcitriol in Combination With ZD1839 (IRESSA®) in Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-01-13Escalating Irinotecan (CPT-11) Administered 24 Hours Prior To Gemcitabine In Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-01-13A Phase I and Pharmacokinetic Study of Selenomethionine With Fixed Dose Irinotecan in Advanced Solid Tumors